Zinzino AB (publ) (9EE.F)
| Previous close | 6.83 |
| Open | 6.84 |
| Bid | 6.71 x N/A |
| Ask | 6.92 x N/A |
| Day's range | 6.84 - 6.84 |
| 52-week range | 2.93 - 7.58 |
| Volume | |
| Avg. volume | 923 |
| Market cap | 231.731M |
| Beta (5Y monthly) | 1.41 |
| PE ratio (TTM) | 17.10 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 0.26 (3.77%) |
| Ex-dividend date | 28 May 2024 |
| 1y target est | N/A |
- PR Newswire
ZINZINO AB (PUBL): NOTICE OF ANNUAL GENERAL MEETING IN ZINZINO AB ON MAY 27, 2024
Shareholders of Zinzino AB (publ) are hereby invited to the annual general meeting on Monday, May 27, 2024, at 1:30 PM at the company's premises at Hulda Mellgrens gata 5 in Gothenburg. Registration begins at 1:15 PM.
- PR Newswire
ZINZINO AB (PUBL): Zinzino and ACN, enter a strategic partnership in Europe, and in connection with it Zinzino carries out a directed new issue of B shares for SEK 10.4 million
Zinzino, the global health and wellness brand from Scandinavia, has entered into a strategic agreement in Europe to partner with North American ACN, a direct seller of telecommunications, energy, and essential services for homes and businesses, which has decided to wind down its direct selling operations in Europe. The agreement between the companies includes that Zinzino takes over the rights to ACN's European distributor database register free of charge, which will in the future be integrated
- PR Newswire
ZINZINO AB (PUBL): PRELIMINARY SALES REPORT OCTOBER 2023
The revenue in October for Zinzino's sales markets increased by 22 % and amounted to SEK 156.2 (128.5) million. Faun Pharma's external sales increased by 20 % and amounted to SEK 5.9 (4.9) million. Overall, the Group increased revenues by 22 % to SEK 162.1 (133.4) million compared with the previous year.
